Abstract
Complement factor C6 plays a critical role in mediating hyperacute rejection of discordant xenografts. In order to explore the mechanism of discordant xenograft rejection, we investigated kinetics and phenotypes of the cellular infiltrate in xenografts in untreated and leukocyte-depleted recipients, in relation to graft survival. Guinea pig cardiac xenografts were heterotopically transplanted to totally C6-deficient PVG (C–) rats. Grafts were removed after 0, 6, 12, and 24 h (n=6). Histological evaluation was performed with hematoxylin and eosin (H & E) and immunoperoxidase staining. The agents fucoidin and busulfan were applied to delay xenograft rejection further. Within 6 h, minimal perivascular edema with isolated infiltrating CD11b/c- and ED1-positive cells were found. An intense infiltration of CD11b/c- and ED1–positive cells with interstitial hemorrhage was present after 24 h, though with little CD161 and CD3 cell infiltration. Inhibition of cell adhesion by fucoidin did not prolong xenograft survival (34±15 h, n=4, P<0.47), but the depletion of granulocytes by injection of busulfan did prolong survival of the discordant xenografts, to 62±22 h (n=7, P≤0.0039). These results demonstrate a significant effect of specific depletion of granulocytes and macrophages by busulfan therapy on guinea pig cardiac xenograft survival in PVG (C–) rats, suggesting the participation of these infiltrating cells in the xenoreactive rejection process.
Similar content being viewed by others
References
Bach FH, Robson SC, Ferran C, Winkler H, Millan MT, Stuhlmeier KM, Vanhove B, Blakely ML, van der Werf WJ, Hofer E, De Martin R, Hancock WW (1994) Endothelial cell activation and thromboregulation during xenograft rejection. Immunol Rev 141:5–30
Blakely ML, van der Werf WJ, Berndt MC, Dalmasso AP, Bach FH, Hancock WW (1994) Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. Transplantation 58:1059–1066
Brauer RB, Baldwin WM III, Daha MR, Pruitt SK, Sanfilippo F (1993) Use of C6-deficient rats to evaluate the mechanism of hyperacute rejection of discordant cardiac xenografts. J Immunol 151:7240–7248
Brauer RB, Baldwin WM III, Pruitt SK, Sanfilippo F (1994) Survival of guinea pig cardiac xenografts in C6-deficient PVG rats treated with monoclonal antibody to CD18. Transplant Proc 26:1251
Brauer RB, Baldwin WM III, Sanfilippo F (1994) The use of C-deficient animals to evaluate the mechanism of hyperacute rejection in discordant xenografting. Xeno 2:1–3
Brauer RB, Baldwin WM III, Wang D, Horwitz LR, Hess AD, Klein AS, Sanfilippo F (1994) Hepatic and extrahepatic biosynthesis of complement factor C6 in the rat. J Immunol 153:3168–3176
Brauer RB, Lam TT, Wang D, Horwitz LR, Hess AD, Klein AS, Sanfilippo F, Baldwin WM III (1995) Extrahepatic synthesis of C6 in the rat is sufficient for complement-mediated hyperacute rejection of guinea pig cardiac xenograft. Transplantation 59:1073–1076
Brauer RB, Baldwin WM III, Wang D, Pruitt SK, Klein AS, Sanfilippo F (1996) Functional activity of anti-C6 antibodies elicited in C6-deficient rats reconstituted by liver allografts: ability to inhibit hyperacute rejection of discordant cardiac xenografts. Transplantation 61:588–594
Brauer RB, Gegenfurtner C, Neumann B, Stadler M, Heidecke CD, Holzmann B (2000) Endotoxin-induced lung inflammation is independent of the complement membrane attack complex. Infect Immun 68:1626–1632
Brodsky I, Bulova S, Crilley P (1989) The role of busulfan/cyclophosphamide regimens in allogeneic and autologous bone marrow transplantation. Cancer Invest 7:509–513
Carrington CA, Richards AC, Cozzi E, Langford G, Yannoutsos N, White DJ (1995) Expression of human DAF and MCP on pig endothelial cells protects from human complement. Transplant Proc 27:321–323
Coughlan AF, Berndt MC, Dunlop LC, Hancock WW (1993) In vivo studies of P-selectin and platelet-activating factor during endotoxemia, accelerated allograft rejection, and discordant xenograft rejection. Transplant Proc 25:2930–2931
Davis EA, Lam TT, Qian Z, Ibrahim S, Baldwin WM III, Sanfilippo FP (1995) Inhibition of neutrophil adhesion and the membrane attack complex of complement synergistically prolongs cardiac xenograft survival. J Heart Lung Transplant 14:973–980
Davis EA, Pruitt SK, Greene PS, Ibrahim S, Lam TT, Levin JL, Baldwin WM III, Sanfilippo F (1996) Inhibition of complement, evoked antibody, and cellular response prevents rejection of pig-to-primate cardiac xenografts. Transplantation 62:1018–1023
DiScipio RG, Daffern PJ, Jagels MA, Broide DH, Sriramarao P (1999) A comparison of C3a- and C5a-mediated stable adhesion of rolling eosinophils in postcapillary venules and transendothelial migration in vitro and in vivo. J Immunol 162:1127–1136
Elson LA, Galton DA, Till M (1958) The action of chlorambucil (CB1348) and busulfan (Myleran) on the haemopoietic organ of the rat. Br J Haematol 4:355–374
Fischer AC, Beschorner WE, Hess AD (1989) Requirements for the induction and adoptive transfer of cyclosporine-induced syngeneic graft-versus-host disease. J Exp Med 169:1031–1041
Geng JG, Bevilacqua MP, Moore KL, McIntyre TM, Prescott SM, Kim JM, Bliss GA, Zimmerman GA, McEver RP (1990) Rapid neutrophil adhesion to activated endothelium mediated by GMP-140. Nature 343:757–760
Granert C, Raud J, Xie X, Lindquist L, Lindbom L (1994) Inhibition of leukocyte rolling with polysaccharide fucoidin prevents pleocytosis in experimental meningitis in the rabbit. J Clin Invest 93:929–936
Hayashi S, Ito M, Yokoyama I, Uchida K, Takagi H (1993) Effectiveness of combination therapy using cobra venom factor, splenectomy, and desoxyspergualin in guinea pig-to-rat cardiac xenografts. Transplant Proc 25:405–406
Jakobs FM, Davis EA, Qian Z, Liu DY, Baldwin WM III, Sanfilippo F (1997) The role of CD11b/CD18-mediated neutrophil adhesion in complement-deficient xenograft recipients. Clin Transplant 11:516–521
Jakobs FM, Davis EA, White T, Sanfilippo F, Baldwin WM III (1998) Prolonged discordant xenograft survival by inhibition of the intrinsic coagulation pathway in complement C6-deficient recipients. J Heart Lung Transplant 17:306–311
Kubes P, Jutila M, Payne D (1995) Therapeutic potential of inhibiting leukocyte rolling in ischemia/reperfusion. J Clin Invest 95:2510–2519
Leventhal JR, Dalmasso AP, Cromwell JW, Platt JL, Manivel CJ, Bolman RD, Matas AJ (1993) Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 55:857–865
Leventhal JR, Sakiyalak P, Witson J, Simone P, Matas AJ, Bolman RM, Dalmasso AP (1994) The synergistic effect of combined antibody and complement depletion on discordant cardiac xenograft survival in nonhuman primates. Transplantation 57:974–978
Ley K, Linnemann G, Meinen M, Stoolman LM, Gaehtgens P (1993) Fucoidin, but not yeast polyphosphomannan PPME, inhibits leukocyte rolling in venules of the rat mesentery. Blood 81:177–185
Linke R, Wagner F, Terajima H, Thiery J, Teupser D, Leiderer R, Hammer C (1998) Prevention of initial perfusion failure during xenogeneic ex vivo liver perfusion by selectin inhibition. Transplantation 66:1265–1272
Ono K, Lindsey ES (1969) Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 57:225–229
Pascher A, Poehlein CH, Storck M, Abendroth D, Mueller-Hoecker J, Young VK, Koenig W, White DJ, Hammer C (1996) Human decay-accelerating factor expressed on endothelial cells of transgenic pigs affects complement activation in an ex vivo liver perfusion model. Transplant Proc 28:754–755
Platt JL (1996) The immunological barriers to xenotransplantation. Crit Rev Immunol 16:331–358
Platt JL (1997) Xenotransplantation: a potential solution to the shortage of donor organs. Transplant Proc 29:3324–3326
Pruitt SK, Baldwin WM III, Marsh HC Jr, Lin SS, Yeh CG, Bollinger RR (1991) The effect of soluble complement receptor type 1 on hyperacute xenograft rejection. Transplantation 52:868–873
Pruitt SK, Kirk AD, Bollinger RR, Marsh HC Jr, Collins BH, Levin JL, Mault JR, Heinle JS, Ibrahim S, Rudolph AR, Baldwin WM III, Sanfilippo F (1994) The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation 57:363–370
Pruitt S, Bollinger RR, Collins BH, Marsh HC, Levin JL, Rudolph AR, Baldwin WM III, Sanfilippo F (1996) Continuous complement (C) inhibition using soluble C-receptor type 1 (sCR1): effect on hyperacute rejection (HAR) of pig-to-primate cardiac xenografts. Transplant Proc 28:756
Pruitt SK, Bollinger RR, Collins BH, Marsh HC Jr, Levin JL, Rudolph AR, Baldwin WM III, Sanfilippo F (1997) Effect of continuous complement inhibition using soluble complement receptor type 1 on survival of pig-to-primate cardiac xenografts. Transplantation 63:900–902
Santos GW (1993) The development of busulfan/cyclophosphamide preoperative regimens. Semin Oncol 20 [Suppl 4]:12–16
Santos GW, Tutschka PJ (1974) Marrow transplantation in the busulfan-treated rat: preclinical model of aplastic anemia. J Natl Cancer Inst 53:1781–1785
Schmoeckel M, Nollert G, Shahmohammadi M, Young VK, Knig W, White DJ, Hammer C, Reichart B (1996) Human decay-accelerating factor successfully protects pig hearts from hyperacute rejection by human blood. Transplant Proc 28:768–769
Tavakoli R, Michel A, Cardoso J, Ayani E, Maillet F, Fontaliran F, Crougneau S, Weill B, Houssin D (1993) Prolonged survival of guinea pig-to-rat heart xenografts using repeated low doses of cobra venom factor. Transplant Proc 25:407–409
Tucker AW, Carrington CA, Richards AC, Robson SC, White DJ (1997) Endothelial cells from human decay acceleration factor transgenic pigs are protected against complement-mediated tissue factor expression in vitro. Transplant Proc 29:888
Tutschka PJ, Santos GW (1975) Bone marrow transplantation in the busulfan-treated rat. II. Effect of cyclophosphamide and antithymic serum on the presensitized state. Transplantation 20:116–122
Van Dixhoorn MG, Timmerman JJ, van Gijlswijk-Janssen DJ, Muizert Y, Verweij C, DiScipio RG, Daha MR (1997) Characterization of complement C6 deficiency in a PVG/c rat strain. Clin Exp Immunol 109:387–396
Weisman HF, Bartow T, Leppo MK, Marsh HJ, Carson GR, Concino MF, Boyle MP, Roux KH, Weisfeldt ML, Fearon DT (1990) Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 249:146–151
Wu G, Korsgren O, van Rooijen N, Wennberg L, Tibell A (1999) The effect of macrophage depletion on delayed xenograft rejection: studies in the guinea pig-to-C6-deficient rat heart transplantation model. Xenotransplantation 6:262–270
Wu GS, Korsgren O, Wennberg L, Tibell A (1999) Deoxyspergualin delays xenograft rejection in the guinea pig-to-C6-deficient rat heart transplantation model. Transpl Int 12:415–422
Zehr KJ, Herskowitz A, Lee PC, Kumar P, Gillinov AM, Baumgartner WA (1994) Neutrophil adhesion and complement inhibition prolongs survival of cardiac xenografts in discordant species. Transplantation 57:900–906
Acknowledgements
We wish to thank Dr. William M. Baldwin III for his advice and for carefully reading the manuscript.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Brauer, R.B., Beck, T., Stehle, I. et al. Busulfan depletes neutrophils and delays accelerated acute rejection of discordant xenografts in the guinea pig-to-rat model. Transpl Int 16, 37–44 (2003). https://doi.org/10.1007/s00147-002-0504-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00147-002-0504-z